Propofol and the risk of transmission of infection;Le propofol et le risque de transmission d'infection

Canadian Journal of Anesthesia

Volumn 50, Issue 6, 2003, Pages 533-537

  Trépanier, Claude A ^a   Lessard, Martin R ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ANESTHESIST; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; DISEASE TRANSMISSION; DRUG CONTAMINATION; DRUG FATALITY; DRUG FORMULATION; EDITORIAL; FILTER; HEPATITIS C; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; PRIORITY JOURNAL; SAFETY; SEPSIS; STAPHYLOCOCCUS INFECTION; VIRUS INFECTION;

EID: 17644448546     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018635     Document Type: Editorial

References (17)

1. Sosis MB, Braverman B. Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 1993; 77: 766-8.
2. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333: 147-54.
3. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 2001; 29: 312-5.
4. Kuehnert MJ, Webb RM, Jochimsen EM, et al. Staphylococcus Aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol. Anesth Analg 1997; 85: 420-5.
5. McNeil MM, Lasker BA, Lott TJ, Jarvis WR. Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agent. J Clin Microbiol 1999; 37: 1398-403.
6. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262-77.
7. American Society of Anesthesiologists. Committee on occupational health of operating room personnel. Recommendations for Infection Control for the Practice of Anesthesiology, 2nd ed. Park Ridge: IL. American Society of Anesthesiologists; 1998.
8. Berry AJ. Recommendations for Handling Parenteral Medications Used for Anesthesia or Sedation. Pittsburg: PA. Anesthesia Patient Safety Foundation; 1995.
9. Zacher AN, Zornow MH, Evans G. Drug contamination from opening glass ampules. Anesthesiology 1991; 75: 893-5.
10. Rosenberg AD, Bernstein DB, Bernstein RL, Skovron ML, Ramanathan S, Turndorf H. Accidental needlesticks: do anesthesiologists practice proper infection control precautions? Am J Anesthesiol 1995; 22: 125-32.
11. Lorenz IH, Kolbitsch C, Lass-Flörl C, et al. Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations. Can J Anesth 2002; 49: 347-52.
12. Lessard MR, Trépanier CA, Gourdeau M, Denault PH. A microbiologigal study of the contamination of the syringes used in anaesthesia practice. Can J Anaesth 1988; 35: 567-9.
13. Trépanier CA, Lessard MR, Brochu JG, Denault PH. Risk of cross-infection related to the multiple use of disposable syringes. Can J Anaesth 1990; 37: 156-9.
14. Lessard MR, Trépanier CA. Use and misuse of syringes in anaesthesia (Editorial). Can J Anaesth 1997; 44: 793-7.
15. Hall WCE, Jolly DT, Hrazdil J, Galbraith JC, Greacen M, Clanachan AS. The EmulSiv™ filter removes microbial contamination from propofol but is not a substitute for aseptic technique. Can J Anesth 2003; 50: 541-6.
16. Bach A, Motsch J, Schmidt H, et al. In-use contamination of propofol. A clinical study. Eur J Anaesthesiol 1997; 14: 178-83.
17. Greene ES. Hepatitis C outbreak: more than 50 infected by reused needles and syringes. ASA newsletter 2002; 66: 22-3.